164 related articles for article (PubMed ID: 7299925)
1. Metabolic effects of bendroflumethiazide in patients with recurrent calcium oxalate stone disease.
Ahlstrand C; Tiselius HG
J Urol; 1981 Nov; 126(5):635-9. PubMed ID: 7299925
[TBL] [Abstract][Full Text] [Related]
2. Diurnal variation of urine composition in calcium oxalate stone disease during treatment with bendroflumethiazide.
Ahlstrand C; Tiselius HG; Larsson L
Eur Urol; 1984; 10(4):260-5. PubMed ID: 6541131
[TBL] [Abstract][Full Text] [Related]
3. Biochemical effects in patients with calcium oxalate stone disease during combined treatment with bendroflumethiazide and magnesium oxide.
Ahlstrand C; Tiselius HG
Br J Urol; 1984 Apr; 56(2):125-30. PubMed ID: 6498431
[TBL] [Abstract][Full Text] [Related]
4. [Metabolic studies in patients with urinary calculi].
Bach D
Z Urol Nephrol; 1982 Jul; 75(7):545-52. PubMed ID: 7148172
[No Abstract] [Full Text] [Related]
5. The role of overweight and obesity in calcium oxalate stone formation.
Siener R; Glatz S; Nicolay C; Hesse A
Obes Res; 2004 Jan; 12(1):106-13. PubMed ID: 14742848
[TBL] [Abstract][Full Text] [Related]
6. Urine composition in patients with urolithiasis during treatment with magnesium oxide.
Tiselius HG; Ahlstrand C; Larsson L
Urol Res; 1980; 8(4):197-206. PubMed ID: 7222314
[TBL] [Abstract][Full Text] [Related]
7. Changes in urinary parameters after oral administration of potassium-sodium citrate and magnesium oxide to prevent urolithiasis.
Kato Y; Yamaguchi S; Yachiku S; Nakazono S; Hori J; Wada N; Hou K
Urology; 2004 Jan; 63(1):7-11; discussion 11-2. PubMed ID: 14751336
[TBL] [Abstract][Full Text] [Related]
8. Urinary magnesium and oxalic acid excretion in patients with recurrent oxalate urolithiasis.
Takasaki E
Invest Urol; 1975 Jan; 12(4):251-4. PubMed ID: 1112654
[TBL] [Abstract][Full Text] [Related]
9. [Oxalate stone prophylaxis by alkalinizing therapy (author's transl)].
Butz M
Urologe A; 1982 May; 21(3):142-6. PubMed ID: 7048691
[TBL] [Abstract][Full Text] [Related]
10. Acute acid load in recurrent oxalate stone formers.
Knispel HH; Fitzner R; Kaiser M; Butz M
Urol Int; 1988; 43(2):93-6. PubMed ID: 3388639
[TBL] [Abstract][Full Text] [Related]
11. How are urine composition and stone disease affected by therapeutic measures at an outpatient stone clinic?
Tiselius HG; Sandvall K
Eur Urol; 1990; 17(3):206-12. PubMed ID: 2351189
[TBL] [Abstract][Full Text] [Related]
12. [Effect of cocoa on excretion of oxalate, citrate, magnesium and calcium in the urine of children].
Lagemann M; Anders D; Graef V; Bödeker RH
Monatsschr Kinderheilkd; 1985 Oct; 133(10):754-9. PubMed ID: 4069117
[TBL] [Abstract][Full Text] [Related]
13. Urinary excretion of calcium, magnesium, oxalate and citrate in duodenal ulcer patients. Preliminary results before and up to five years after highly selective vagotomy.
Schwille PO; Scholz D; Hanisch E; Zeuner E; Schwendtner H; Husemann B; Mühe E; Sigel A
Klin Wochenschr; 1983 Sep; 61(17):845-50. PubMed ID: 6632726
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience with long-term bendroflumethiazide treatment in calcium oxalate stone formers.
Ahlstrand C; Tiselius HG; Larsson L; Hellgren E
Br J Urol; 1984 Jun; 56(3):255-62. PubMed ID: 6399984
[TBL] [Abstract][Full Text] [Related]
15. [Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].
Murayama T; Taguchi H
Hinyokika Kiyo; 1987 Sep; 33(9):1321-30. PubMed ID: 3434487
[TBL] [Abstract][Full Text] [Related]
16. A biochemical basis for grouping of patients with urolithiasis.
Tiselius HG; Almgård LE; Larsson L; Sörbo B
Eur Urol; 1978; 4(4):241-9. PubMed ID: 668734
[TBL] [Abstract][Full Text] [Related]
17. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
Schwille PO; Schmiedl A; Manoharan M
Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
[TBL] [Abstract][Full Text] [Related]
18. Influence of magnesium on the absorption and excretion of calcium and oxalate ions.
Berg W; Bothor C; Pirlich W; Janitzky V
Eur Urol; 1986; 12(4):274-82. PubMed ID: 3743598
[TBL] [Abstract][Full Text] [Related]
19. Changes in urinary composition of calcium oxalate stone formers.
Rahman B; Rahman MA
Biomed Pharmacother; 1986; 40(3):108-10. PubMed ID: 3742009
[TBL] [Abstract][Full Text] [Related]
20. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
